Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study

OBJECTIVE: To assess whether the use of dipeptidyl peptidase-4 inhibitors is associated with the incidence of inflammatory bowel disease in patients with type 2 diabetes. DESIGN: Population based cohort study. SETTING: More than 700 general practices contributing data to the United Kingdom Clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrahami, Devin, Douros, Antonios, Yin, Hui, Yu, Oriana Hoi Yun, Renoux, Christel, Bitton, Alain, Azoulay, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861502/
https://www.ncbi.nlm.nih.gov/pubmed/29563098
http://dx.doi.org/10.1136/bmj.k872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861502/
https://www.ncbi.nlm.nih.gov/pubmed/29563098
http://dx.doi.org/10.1136/bmj.k872

Ejemplares similares